Chalkis Health Industry Co., Ltd

Total Valuation

Chalkis Health Industry Co., Ltd carries a market capitalization of 2.76B, placing it among publicly traded companies globally. Its enterprise value stands at 3.40B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Chalkis Health Industry Co., Ltd currently has 771.28M shares outstanding.

Valuation Ratios

Chalkis Health Industry Co., Ltd trades at a trailing price-to-earnings ratio of 26.00. The price-to-sales ratio is 8.92, and the price-to-book ratio stands at -2.27.

Enterprise Valuation

On an enterprise value basis, Chalkis Health Industry Co., Ltd trades at an EV/EBITDA multiple of 12.21 and an EV/FCF ratio of 51.88. The EV/Sales ratio of 11.06 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.21 provides insight into valuation relative to core operating earnings.

Financial Position

Chalkis Health Industry Co., Ltd maintains a current ratio of 0.71, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -761.86, indicating conservative leverage, while an interest coverage ratio of -3.24 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Chalkis Health Industry Co., Ltd's stock has gained approximately 1.41643% over the past 52 weeks. The 50-day moving average sits at 3.82, while the 200-day moving average is 3.86.

Income Statement

Over the trailing twelve months, Chalkis Health Industry Co., Ltd generated 307.96M in revenue and converted that into -317.28M in net income, yielding earnings per share of -0.42. EBITDA reached -115.15M, while operating income came in at -115.15M.

Balance Sheet

Chalkis Health Industry Co., Ltd holds 66.42M in cash and equivalents against 714.89M in total debt, resulting in a net debt position of 608.45M. Total book value stands at -1.21B, with working capital of -377.62M providing operational flexibility.

Cash Flow

After subtracting -29.85M in capital expenditures, free cash flow totaled -29.85M - equivalent to -0.04 per share.

Margins

Chalkis Health Industry Co., Ltd operates with a gross margin of -11.78, reflecting its pricing power and cost economics. The operating margin of -37.39 and net profit margin of -103.03 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of -9.36 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Chalkis Health Industry Co., Ltd's most recent stock split took place on February 22, 2013 with a 5:8 split ratio.

Scores

Chalkis Health Industry Co., Ltd posts an Altman Z-Score of -1.30, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.